ESR1 and breast carcinoma: Taken together, our data demonstrated that KDM5C can activate estrogen/ERα‐target genes to promote cell growth as well as repress type I IFNs and ISGs to escape from immune surveillance, both of which might contribute to its oncogenic function in ERα‐positive breast cancers.